MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-20-0008290
Larsen Formulations Private Limited
Larsen Formulations Private Limited - chemicals in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹2.22 Cr
▲ 15% YoY
Net profit · FY 2025
₹2.7 Lakh
Net margin 1.2%
EBITDA · FY 2025
₹3.94 Lakh
EBITDA margin 1.8%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
16
Provident fund records
Directors on board
4
As per MCA filings
About Larsen Formulations Private Limited
Data last updated:
Larsen Formulations Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 13 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24299MH2021PTC353409.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Parthasarathynaidu Rayapati and Lokeswari Gunturi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 302 Tasai Darshan Shree Malang Road Near Nandiwali Talav Kalyan East Thane, Mumbai, Maharashtra, India – 421306.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.22 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹2.7 Lakh (net margin 1.2%) and EBITDA of ₹3.94 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 50% over three years.
The company has about 16 employees on its provident fund (EPFO) records.
Larsen Formulations Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0008290).
Company details
CIN U24299MH2021PTC353409
Registration Number 353409
Incorporation Date 13 January 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0008290
Recognitions & Rankings of Larsen Formulations
Contact details
Larsen Formulations Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressA – 302 Tasai Darshan Shree Malang Road Near Nandiwali Talav Kalyan East Thane, Mumbai, Maharashtra, India – 421306
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
Comprehensive company report
Larsen Formulations Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Larsen Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Larsen Formulations Private Limited, buy the company report.
Financials of Larsen Formulations Private Limited
FY 2025 filings availableLarsen Formulations Private Limited reported revenue of ₹2.22 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹2.22 Cr ▲ 15%
Net profit · FY 2025
₹2.7 Lakh margin 1.2%
EBITDA · FY 2025
₹3.94 Lakh margin 1.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 50%
EBITDA CAGR growth
1 year
▲ 46%
3 years · compounded
▲ 39%
Revenue has grown at a compounded annual rate (CAGR) of 50% over three years, including 15% growth in the latest year. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.94 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.7 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.8% | ||||
| Net Profit Margin | 1.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Larsen Formulations Private Limited, buy the company report.
Board of directors of Larsen Formulations Private Limited
Larsen Formulations has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parthasarathynaidu Rayapati | Director | 13 Jan 2021 | 5 Years 9 Months | Current |
| Lokeswari Gunturi | Director | 13 Nov 2024 | 1 Years 11 Months | Current |
| Ravoori Sravani | Director | 13 Nov 2024 | 1 Years 11 Months | Current |
| Bharath Chandra Gurram | Director | 13 Jan 2021 | 5 Years 9 Months | Current |
Peer comparison
Larsen Formulations Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mehta Pharmaceuticals Private Limited | ₹2.23 Cr (FY 2024) | -71.0% | Amritsar, Punjab, India | |||
| Sayora Pharma Private Limited | ₹2.23 Cr (FY 2024) | 16.0% | Chandigarh, India | |||
| Swiss Medicare Private Limited | ₹2.22 Cr (FY 2025) | 12.0% | Sri Ganganagar, Rajasthan, India | |||
| Larsen Formulations Private Limitedthis company | ₹2.22 Cr (FY 2025) | ₹2.7 Lakh | 1.2% | 15.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Larsen Formulations Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Larsen Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Larsen Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Larsen Formulations Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Larsen Formulations Private Limited has 4 board changes on record since 2021: 4 appointments. The latest: Lokeswari Gunturi was appointed as Director on 13 Nov 2024.
AGM
Larsen Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Larsen Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Appointed
Lokeswari Gunturi was appointed as Director.
Appointed
Ravoori Sravani was appointed as Director.
Appointed
Bharath Chandra Gurram was appointed as Director.
Appointed
Parthasarathynaidu Rayapati was appointed as Director.
Incorporation
13 Jan 2021
Larsen Formulations Private Limited was registered on 13 Jan 2021 with Roc Mumbai Ii & aged 5 years 9 months as per MCA records.
Frequently asked questions
Larsen Formulations is an active private limited company based in Mumbai, Maharashtra, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 13 January 2021 (5+ years old) and is registered under CIN U24299MH2021PTC353409.
Larsen Formulations has 4 current directors:
- Parthasarathynaidu Rayapati - Director
- Lokeswari Gunturi - Director
- Ravoori Sravani - Director
- Bharath Chandra Gurram - Director
The latest financial statements of Larsen Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Larsen Formulations is U24299MH2021PTC353409. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Larsen Formulations was incorporated on 13 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Larsen Formulations by revenue are Mehta Pharmaceuticals Private Limited, Sayora Pharma Private Limited, Swiss Medicare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Lokeswari Gunturi was appointed as Director on 13 Nov 2024. Ravoori Sravani was appointed as Director on 13 Nov 2024. Bharath Chandra Gurram was appointed as Director on 13 Jan 2021. Larsen Formulations has 4 board changes on record in total.
Yes, Larsen Formulations is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0008290).
The registered office of Larsen Formulations is at A – 302 Tasai Darshan Shree Malang Road Near Nandiwali Talav Kalyan East Thane, Mumbai, Maharashtra, India – 421306.
Larsen Formulations operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Larsen Formulations can be reached at its registered office: A – 302 Tasai Darshan Shree Malang Road Near Nandiwali Talav Kalyan East Thane, Mumbai, Maharashtra, India – 421306.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages